Skip to content

CBLL

Ceribell, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$27.47
−2.84%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue108.7M89.1M65.4M45.2M25.9M
Cost of Revenue11.7M10.8M8.7M7.1M4.4M
Gross Profit97.0M78.3M56.8M38.2M21.5M
Operating Expenses
R&D Expense25.4M19.1M13.6M9.0M7.2M
SG&A Expense147.5M117.5M82.9M59.2M50.3M
General & Admin Expense56.6M44.5M33.8M20.3M18.5M
Selling & Marketing Expense90.9M73.1M49.1M38.9M31.8M
Other Expenses—————
Total Operating Expenses172.9M136.7M96.5M68.2M57.5M
Cost and Expenses184.6M147.5M105.2M75.3M61.9M
Operating Income (EBIT)(75.9M)(58.4M)(39.7M)(30.0M)(36.0M)
Non-Operating
Interest Income—————
Interest Expense1.1M1.9M2.0M2.1M1.6M
Net Interest Income(1.3M)(1.9M)(2.0M)(2.1M)(1.6M)
Other Non-Op Income/Expense2.0M5.0M(746.0K)588.0K(1.1M)
Non-Operating Income (excl Interest)(4.1M)(6.9M)(1.2M)(2.7M)(462.0K)
EBT (Pre-Tax Income)(73.9M)(53.4M)(40.5M)(29.5M)(37.2M)
Income Tax Expense———11.0K2.0K
Bottom Line
Net Income(73.9M)(53.4M)(40.5M)(29.5M)(37.2M)
Earnings from Cont. Ops(73.9M)(53.4M)(40.5M)(29.5M)(37.2M)
Earnings from Discont. Ops—————
Bottom Line Net Income(73.9M)(53.4M)(40.5M)(29.5M)(37.2M)
Per Share
Basic EPS($1.94)($1.46)($1.13)($1.26)($1.59)
Diluted EPS($1.94)($1.46)($1.13)($1.26)($1.59)
Revenue Per Share$2.82$2.44$1.83$1.94$1.11
Shares
Basic Shares Outstanding38.5M36.5M35.9M23.3M23.3M
Diluted Shares Outstanding38.5M36.5M35.9M23.3M23.3M
Profitability Metrics
EBITDA(71.0M)(50.2M)(37.3M)(26.5M)(35.1M)
D&A775.0K1.3M1.1M847.0K497.0K
EBIT(51.2M)(51.5M)(38.5M)(27.4M)(35.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026